Trials / Completed
CompletedNCT04066283
Effects of Aging and Gender-Affirming Hormone Therapy on Vascular Endothelial Function and Metabolic Profiles in Transgender Women
Novel Evaluations of Aging and Gender-Affirming Hormone Therapy on Vascular Endothelial Function and Metabolic Profiles in Transgender Women Compared to Age Group-Matched Cisgender Adults
- Status
- Completed
- Phase
- —
- Study type
- Observational
- Enrollment
- 29 (actual)
- Sponsor
- University of Colorado, Denver · Academic / Other
- Sex
- All
- Age
- 18 Years – 75 Years
- Healthy volunteers
- Accepted
Summary
This study will examine markers of vascular endothelial function (vascular health) and metabolic profiles in younger versus older transgender women (people who were assigned male at birth but whose gender identity is female). Data will also be compared to those from cisgender women and men.
Conditions
- Transgender
- Gender Identity
- Vascular Stiffness
- Vascular Inflammation
- Insulin Sensitivity
- Blood Pressure
- Lipid Disorder
- Appetitive Behavior
Interventions
| Type | Name | Description |
|---|---|---|
| OTHER | No intervention | There was no intervention in this study |
Timeline
- Start date
- 2019-04-17
- Primary completion
- 2023-12-31
- Completion
- 2023-12-31
- First posted
- 2019-08-26
- Last updated
- 2024-09-19
Locations
1 site across 1 country: United States
Source: ClinicalTrials.gov record NCT04066283. Inclusion in this directory is not an endorsement.